Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q36060733)
Watch
English
Which Therapy for Helicobacter pylori Infection?
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
3383941
retrieved
11 August 2017
editorial
0 references
title
Which Therapy for Helicobacter pylori Infection?
(English)
1 reference
stated in
Europe PubMed Central
PMCID
3383941
retrieved
11 August 2017
main subject
Helicobacter pylori
0 references
Helicobacter pylori infectious disease
1 reference
based on heuristic
inferred from title
author
David Y. Graham
series ordinal
1
object named as
David Y Graham
1 reference
stated in
Europe PubMed Central
retrieved
11 August 2017
PMCID
3383941
Akiko Shiotani
series ordinal
2
object named as
Akiko Shiotani
1 reference
stated in
Europe PubMed Central
PMCID
3383941
retrieved
11 August 2017
language of work or name
English
0 references
publication date
18 May 2012
1 reference
stated in
Europe PubMed Central
PMCID
3383941
retrieved
11 August 2017
published in
Gastroenterology
1 reference
stated in
Europe PubMed Central
PMCID
3383941
retrieved
11 August 2017
volume
143
1 reference
stated in
Europe PubMed Central
PMCID
3383941
retrieved
11 August 2017
issue
1
1 reference
stated in
Europe PubMed Central
PMCID
3383941
retrieved
11 August 2017
page(s)
10-12
1 reference
stated in
Europe PubMed Central
PMCID
3383941
retrieved
11 August 2017
cites work
Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383941
retrieved
2 October 2017
Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383941
retrieved
2 October 2017
Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383941
retrieved
2 October 2017
Helicobacter pylori treatment in the era of increasing antibiotic resistance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383941
retrieved
2 October 2017
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383941
retrieved
2 October 2017
Efficient identification and evaluation of effective Helicobacter pylori therapies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383941
retrieved
2 October 2017
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383941
retrieved
2 October 2017
Understanding and appreciating sequential therapy for Helicobacter pylori eradication
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383941
retrieved
11 July 2018
Helicobacter pylori therapy demystified
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383941
retrieved
23 September 2018
Helicobacter pylori eradication therapy research: Ethical issues and description of results
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383941
retrieved
23 September 2018
Editorial: Sequential therapy for eradication of Helicobacter pylori: a new guiding light or a false dawn?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383941
retrieved
23 September 2018
Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383941
retrieved
23 September 2018
The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22613622
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22613622
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infection
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22613622
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1053/J.GASTRO.2012.05.012
1 reference
stated in
Europe PubMed Central
PMCID
3383941
retrieved
11 August 2017
PMCID
3383941
1 reference
stated in
Europe PubMed Central
PMCID
3383941
retrieved
11 August 2017
PubMed ID
22613622
1 reference
stated in
Europe PubMed Central
PMCID
3383941
retrieved
11 August 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
